ConductScience.org, home

Paper21148331

RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosis.

Schnittger S and 7 others. Blood, 2011. Cited by 209 papers, by iCite.

Cite this record

ConductScience Library. RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosis. Papers, record 21148331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21148331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosis.
PubMed
Journal
Blood
PubMed
Year
2011
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
209
iCite
Relative citation ratio, by iCite
4.62
iCite
Revised in PubMed
2022-03-31
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schnittger SSusanne
2Dicker FFrank
3Kern WWolfgang
4Wendland NNicole
5Sundermann JJana
6Alpermann TTamara
7Haferlach CClaudia
8Haferlach TTorsten

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Core Binding Factor Alpha 2 SubunitMajor topic
Leukemia, Myeloid, AcuteMajor topic
MutationMajor topic
fms-Like Tyrosine Kinase 3Major topic
Adolescent
Adult
Aged
Aged, 80 and over
Cytogenetic Analysis
Humans
Inverted Repeat Sequences
Kaplan-Meier Estimate
Karyotyping
Leukocyte Count
Middle Aged
Prognosis
Survival Rate
Young Adult

Source PubMed

Download CSV of topics

Cited by119

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 209 citations.

PMIDTitleJournalYearIn PapersSource
42706154[Clinical characteristics and prognosis of acute myeloid leukemia patients with RUNX1 single-site and multiple-site gene mutations].Zhonghua Xue Ye Xue Za Zhi2026https://conductscience.org/library/papers/42706154PubMed
41924923Preemptive hematopoietic stem cell transplantation in RUNX1 familial platelet disorder: a shared decision-making framework.Haematologica2026https://conductscience.org/library/papers/41924923PubMed
41430607The METTL3-YTHDC1 axis mediates architectural RNA m6A modification to modulate the integrity of chromatin TADs in MLLr + AML genome.Mol Cancer2025https://conductscience.org/library/papers/41430607PubMed
41388195A T-cell receptor targeting RUNX1 frameshift mutations in acute myeloid leukemia.Leukemia2026https://conductscience.org/library/papers/41388195PubMed
40763310CBFβ-SMMHC-driven leukemogenesis requires enhanced RUNX1-DNA binding affinity in mice.J Clin Invest2025https://conductscience.org/library/papers/40763310PubMed
40558237Clinical Effects of RUNX1 Mutations on the Outcomes of Patients with Acute Myeloid Leukemia Treated with Allogeneic Hematopoietic Stem-Cell Transplantation.Curr Oncol2025https://conductscience.org/library/papers/40558237PubMed
39822584Disease characteristics and outcomes of acute myeloid leukemia in germline RUNX1 deficiency (Familial Platelet Disorder with associated Myeloid Malignancy).Hemasphere2025https://conductscience.org/library/papers/39822584PubMed
39450904JMJD1C forms condensate to facilitate a RUNX1-dependent gene expression program shared by multiple types of AML cells.Protein Cell2025https://conductscience.org/library/papers/39450904PubMed
39367609Advancements in genetic analysis: Insights from a case study and review of next-generation sequencing techniques for veterinary oncology applications.Vet Clin Pathol2025https://conductscience.org/library/papers/39367609PubMed
38316746Efficacy of novel agents against cellular models of familial platelet disorder with myeloid malignancy (FPD-MM).Blood Cancer J2024https://conductscience.org/library/papers/38316746PubMed
37188777RUNX1 mutation has no prognostic significance in paediatric AML: a retrospective study of the AML-BFM study group.Leukemia2023https://conductscience.org/library/papers/37188777PubMed
36788336Control of focal adhesion kinase activation by RUNX1-regulated miRNAs in high-risk AML.Leukemia2023https://conductscience.org/library/papers/36788336PubMed
36544784Establishment and validation of a carbohydrate metabolism-related gene signature for prognostic model and immune response in acute myeloid leukemia.Front Immunol2022https://conductscience.org/library/papers/36544784PubMed
36463299Shaking up the silence: consequences of HMGN1 antagonizing PRC2 in the Down syndrome brain.Epigenetics Chromatin2022https://conductscience.org/library/papers/36463299PubMed
36358658Clinical Outcomes of Acute Myeloid Leukemia Patients Harboring the RUNX1 Mutation: Is It Still an Unfavorable Prognosis? A Cohort Study and Meta-Analysis.Cancers (Basel)2022https://conductscience.org/library/papers/36358658PubMed
36232714RUNX1/CEBPA Mutation in Acute Myeloid Leukemia Promotes Hypermethylation and Indicates for Demethylation Therapy.Int J Mol Sci2022https://conductscience.org/library/papers/36232714PubMed
36077669Genetics and Epigenetics in Neoplasms with Plasmacytoid Dendritic Cells.Cancers (Basel)2022https://conductscience.org/library/papers/36077669PubMed
35884618NF-κB: A Druggable Target in Acute Myeloid Leukemia.Cancers (Basel)2022https://conductscience.org/library/papers/35884618PubMed
35884612Plasmacytoid Dendritic Cells, a Novel Target in Myeloid Neoplasms.Cancers (Basel)2022https://conductscience.org/library/papers/35884612PubMed
35384048Prediction of survival with intensive chemotherapy in acute myeloid leukemia.Am J Hematol2022https://conductscience.org/library/papers/35384048PubMed

See all 119 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FLT32322PubTator's text mininghttps://conductscience.org/library/genes/2322NCBI Gene
KMT2A4297PubTator's text mininghttps://conductscience.org/library/genes/4297NCBI Gene
NRAS4893PubTator's text mininghttps://conductscience.org/library/genes/4893NCBI Gene
RUNX1861PubTator's text mininghttps://conductscience.org/library/genes/861NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21148331

GET https://conductscience.org/api/papers/v1/21148331/cited_by?page=2